US Bancorp DE Sells 1,380 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

US Bancorp DE lowered its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 14.4% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,179 shares of the company’s stock after selling 1,380 shares during the period. US Bancorp DE’s holdings in Option Care Health were worth $256,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of OPCH. Congress Asset Management Co. raised its position in shares of Option Care Health by 20.9% in the third quarter. Congress Asset Management Co. now owns 341,602 shares of the company’s stock valued at $10,692,000 after buying an additional 58,972 shares in the last quarter. Diversify Wealth Management LLC increased its stake in Option Care Health by 15.3% during the 3rd quarter. Diversify Wealth Management LLC now owns 10,299 shares of the company’s stock worth $309,000 after acquiring an additional 1,364 shares during the period. Pinnacle Associates Ltd. raised its holdings in Option Care Health by 11.6% in the 3rd quarter. Pinnacle Associates Ltd. now owns 30,066 shares of the company’s stock valued at $1,013,000 after acquiring an additional 3,137 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in shares of Option Care Health by 7.0% during the 3rd quarter. Nisa Investment Advisors LLC now owns 14,526 shares of the company’s stock valued at $455,000 after acquiring an additional 945 shares during the period. Finally, State of Alaska Department of Revenue grew its holdings in shares of Option Care Health by 3.8% during the 3rd quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company’s stock worth $621,000 after purchasing an additional 735 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Performance

Shares of Option Care Health stock opened at $22.18 on Thursday. The company’s 50 day moving average price is $29.24 and its two-hundred day moving average price is $29.54. The firm has a market capitalization of $3.77 billion, a P/E ratio of 18.80, a P/E/G ratio of 2.37 and a beta of 1.32. Option Care Health, Inc. has a fifty-two week low of $22.11 and a fifty-two week high of $34.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on OPCH shares. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and dropped their price target for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Barrington Research cut their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. JMP Securities lifted their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Finally, Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $30.83.

Insider Activity

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares in the company, valued at $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is owned by corporate insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.